Nanoinjections of SHU9119 into the dorsal medial hypothalamus had no effects on lumbar sympathetic nerve activity (LSNA), heart rate (HR), or mean arterial pressure (MAP) in obesity-prone (OP, n = 4), obesity-resistant (OR, n = 4), or control (CON, n = 6) rats.